A Systematic Review of Methods and Practice for Integrating Maternal, Fetal, and Child Health Outcomes, and Family Spillover Effects into Cost-Utility Analyses

Ramesh Lamsal,E. Ann Yeh,Eleanor Pullenayegum,Wendy J. Ungar
DOI: https://doi.org/10.1007/s40273-024-01397-5
2024-06-01
PharmacoEconomics
Abstract:Maternal-perinatal interventions delivered during pregnancy or childbirth have unique characteristics that impact the health-related quality of life (HRQoL) of the mother, fetus, and newborn child. However, maternal-perinatal cost-utility analyses (CUAs) often only consider either maternal or child health outcomes. Challenges include, but are not limited to, measuring fetal, newborn, and infant health outcomes, and assessing their impact on maternal HRQoL. It is also important to recognize the impact of maternal-perinatal health on family members' HRQoL (i.e., family spillover effects) and to incorporate these effects in maternal-perinatal CUAs.
pharmacology & pharmacy,health care sciences & services,health policy & services,economics
What problem does this paper attempt to address?